Endometrial Cancer


Phase II study evaluating the role of HER2-directed ADC Trastuzumab deruxtecan (T-DxD)

Minimally Invasive Surgery in Endometrial Cancer

A systematic review and a meta-analysis supporting the safety of MIS in high-risk endometrial cancer

ASTRO Endometrial Cancer Guidelines 2023

Updated ASTRO guidelines and management of endometrial cancer with radiation therapy